LeMaitre Will Announce Second Quarter 2026 Earnings Results on August 4, 2026
LeMaitre (Nasdaq: LMAT) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
LeMaitre (Nasdaq: LMAT) will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company will host a conference call at 5:00 PM EDT the same day to review results, business highlights, and outlook.
Investors can access the live call by registering online to receive dial-in details and a PIN. An audio webcast, including a replay, will be available at ir.lemaitre.com.
Details
News Market Reaction – LMAT
On Jul 15, the first trading day after this news, LMAT closed 1.97% above the previous close. Our momentum scanner recorded 3 alerts in the available session data.
Data tracked by StockTitan Argus for the Jul 15 session.
Key Figures
- Earnings release date
- August 4, 2026
- Second quarter 2026 financial results release after market close
- Conference call time
- 5:00 PM EDT
- Same day as Q2 2026 results to discuss results and outlook
Previous Earnings date Reports
-
Announced Q1 2026 results date with post-close call and webcast details.
-
Set Q4 2025 results release date and 5:00 PM EST conference call.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
AI-generated analysis. How Rhea-AI works. Not financial advice.
BURLINGTON, Mass., July 14, 2026 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT) announced today that it will release its second quarter 2026 financial results on Tuesday, August 4, 2026, after the market close. The company has scheduled a conference call for 5:00 PM EDT the same day to discuss the results, business highlights, and company outlook.
Access to the live call is available by registering online here. All registrants will receive dial-in information and a PIN allowing them to access the live call. The audio webcast can also be accessed live or via replay at ir.lemaitre.com.
About LeMaitre
LeMaitre is a provider of devices, implants, and services for the treatment of peripheral vascular disease, a condition that affects more than 200 million people worldwide. The Company develops, manufactures, and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. Additional information can be found at www.lemaitre.com.
LeMaitre and the LeMaitre logo are registered trademarks of LeMaitre Vascular, Inc.
Contact: Gregory Manker Director, Business Development & Investor Relations LeMaitre Vascular, Inc. +1 781-362-1260 gmanker@lemaitre.com
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.